Gapping up In reaction to strong earnings/guidance: WBAI +6.4%, TTM +5.8%, MFRM +5.1%, RGEN +4.1%, ARMK +3.5%, BITA +2.8%, MPAA +2.3%, USEG +2.3%, HE +1.6%, TSM +0.8%, ADHD +0.6%, ZOES +0.5%.
M&A news: KMI +20.1% (to purchase KMP, KMR and EPB; 2015 KMI dividend to increase to $2 per share), KMR +34.6%, EPB +30.5%, KMP +27.1%.
Other news: PIP +42.9% (Delaware Court of Chancery orders SIGA to pay PharmAthene lump sum expectation damages), DRL +28% (disclosed settlement with the Treasury Department), MNKD +25% (SNY and MannKind announce global licensing agreement for Afrezza rapid-acting inhaled insulin), HGSH +21.5% (will be engaged in large-scale Shanty Areas rebuilding Projects with budgeted investment over $1.3 billion), BIOD +10.5% (concentrated Insulin BIOD-531 demonstrates superior glucose control following standardized meals vs marketed insulins in a Phase 2 Clinical Trial in patients with Type 2 Diabetes), TKMR +7.2% (continued momentum on ebola exposure), BCRX +5.9% (may be related to MNKD news, biotech peer), OXGN +5.7% (maybe related to MNKD news, biotech peer), KNDI +3.6% (may be related to TSLA upgrade, also Shanghai strong overnight), NQ +2.5% (cont volatility), PLUG +2.3% (continued momentum), BYI +2.3% (may be related to acquisition in the space), JD +2.3% (Shanghai strong overnight), MY +2.2% (stong Shanghai overnight), RIO +1.8% (strong Chinese markets overnight), NOK +1.6% (launches new MSFT phone), HLF +1.5% (Capital Research Global Investors discloses 10.1% passive stake in 13G filing), JKS +1.3% (opens solar module factory in Cape Town, South Africa), CCL +1.2% (cruised data released Friday), PVG +0.9% (provides Q2 updates on Brucejack Project; increases in Valley of the Kings mineral grade).
Analyst comments: ACHN +8% (upgraded to Outperform from Market Perform at Wells Fargo, upgraded to Overweight from Neutral at Piper Jaffray), KKD +4.6% (upgraded to Outperform from Neutral at Wedbush), CDNA +4.3% (initiated with a Buy at Mizuho, initiated with a Outperform at Leerink Partners), TSLA +2.7% (upgraded to Buy from Hold at Deutsche Bank), CHUY +2.4% (upgraded to Outperform from Mkt Perform at Raymond James), OAS +2% (upgraded to Buy from Neutral at Sterne Agee), GNC +1.9% (upgraded to Outperform from Neutral at Credit Suisse ), FMS +1.3% (upgraded to Buy from Hold at Societe Generale ), SD +0.9% (upgraded to Reduce from Sell at KLR Group), FCX +0.8% (upgraded to Buy from Hold at Argus), NFLX +0.7% (target raised to $527 at Topeka Capital Markets)